5-Amino-1MQ is a small molecule that has become popular in wellness and longevity circles for its proposed role in fat cell metabolism. Telos rx does not currently offer it for compounding, and this article answers the questions patients ask most often about what it is, how it is discussed, and where things stand today.
What to know: 5-Amino-1MQ is not a peptide chain. It is a small molecule studied as an inhibitor of an enzyme called NNMT. Research on it remains largely preclinical. Telos rx is reviewing it for a future program but does not offer it today, and nothing below should be read as medical advice about starting it on your own.
What is 5-Amino-1MQ
5-Amino-1MQ is a synthetic small molecule studied for its activity against nicotinamide N-methyltransferase, usually shortened to NNMT. NNMT is an enzyme found in fat tissue and the liver, and it plays a role in how cells use methyl groups and manage certain metabolic pathways.
It is worth being precise here. 5-Amino-1MQ is not technically a peptide, since it is not built from a chain of amino acids the way BPC-157 or sermorelin are. It is grouped alongside peptides in wellness marketing because it is researched and compounded in similar settings, but the underlying chemistry is different.
Telos rx does not currently offer 5-Amino-1MQ for compounding. It is not yet part of the telos rx program. A 2026 review of research peptides produced non-binding recommendations rather than regulatory approval, so telos rx has not added it to what it dispenses. You can read more about telos rx's current status on 5-Amino-1MQ.
Patients also ask where the name comes from. It refers to the compound's chemical structure, an amino-substituted quinoline derivative, rather than to any brand or trial name. That naming convention is common across early-stage research compounds discussed online.
Is it the same as a GLP-1 medication
No. GLP-1 medications like compounded semaglutide and tirzepatide work on appetite-regulating hormone pathways in the gut and brain. 5-Amino-1MQ is studied through a different route, aimed at NNMT activity inside fat and liver cells.
Patients sometimes ask this because both are discussed in the context of body composition. The proposed mechanisms have little in common with each other. The research bases are also at very different stages of maturity, since GLP-1 medications have gone through extensive clinical trial programs while 5-Amino-1MQ has not.
If your interest in 5-Amino-1MQ comes from wanting help with weight management specifically, that is a separate conversation worth having directly with a provider about medications that are actually available today. For general background on how weight-management medications are evaluated, see the NIH NIDDK overview of prescription weight-management medication.
Key takeaway: 5-Amino-1MQ is a small molecule NNMT inhibitor, not a classic peptide, and its research base is still mostly preclinical. Telos rx does not currently offer it.
What has research actually looked at
Most of what is published about NNMT inhibition and compounds like 5-Amino-1MQ comes from laboratory and animal research rather than large human trials. That research has examined how blocking NNMT activity might influence fat cell behavior and certain markers of metabolism in those models.
Animal and cell culture findings do not automatically translate to humans. A great deal of promising preclinical research never produces a medication that reaches patients. NNMT inhibition remains an active area of study rather than a settled one. For general background on how the FDA evaluates and regulates compounded substances, see the FDA's overview of human drug compounding.
Patients who ask about 5-Amino-1MQ are often surprised by how early-stage the human data actually is compared to how confidently it is sometimes marketed online. That gap between marketing language and the underlying evidence is worth keeping in mind whenever you read about it.
Why isn't it available if people are researching it
Ongoing research does not mean a substance is ready for a compounding pharmacy to prepare and dispense responsibly. Telos rx works only with partner compounding pharmacies, and it adds a substance to its program only after its own review process, not simply because online interest or discussion has grown.
A non-binding regulatory recommendation is a signal that a topic is being discussed at a policy level. It is not the same as a rule change. It does not create a timeline for when, or whether, a substance becomes available, and telos rx will not suggest a date because none is confirmed.
This caution exists for a reason. Compounded medications are not FDA-approved in the way conventional prescription drugs are, and adding something new to a clinical program is a decision telos rx does not take lightly.
Patients sometimes assume that because a substance is legal to purchase from a research-chemical vendor, it must be close to being offered clinically. Those are two entirely separate standards, and the gap between them can be wide.
Is it safe to source elsewhere
Some patients ask whether they should simply buy 5-Amino-1MQ from an online research-chemical seller instead of waiting. Telos rx cannot speak to the safety, purity, or sourcing practices of sellers outside its own partner pharmacy network, and this article is not a recommendation to do that.
Products sold as research chemicals are typically labeled as not for human consumption. They are not manufactured under the same quality standards as compounded medication that a licensed pharmacy prepares for a specific patient under provider oversight.
If purity, dosing accuracy, and clinical oversight matter to you, and they should, self-sourcing outside a regulated pathway removes all three of those safeguards at once. There is no way for a patient to independently verify what is actually in a vial purchased that way.
What questions should I bring to a provider
If you want to talk through your interest in 5-Amino-1MQ with a clinician, it helps to be specific about your goal. Are you interested in general metabolic health, body composition, or something else entirely? A vague question tends to get a vague answer.
Ask what is actually known versus assumed about the substance, and ask directly whether a provider would consider it appropriate for your situation even if it were available. That conversation can be useful context even while 5-Amino-1MQ remains outside what telos rx currently offers.
Bring your full health history to any conversation like this, since context always shapes how a clinician frames an early-stage research substance and what alternatives might make sense.
How it is typically discussed in longevity communities
5-Amino-1MQ shows up frequently in longevity and biohacking discussions, usually alongside conversations about metabolism, body composition, and cellular energy. Interest tends to come from people already reading broadly about metabolic health rather than from a single well-known source.
That popularity can create a mismatch. A substance can be widely discussed online while still having a thin human research base, and 5-Amino-1MQ is a good example of that gap. Enthusiasm in online communities is not evidence of safety, effectiveness, or regulatory readiness.
It helps to separate three different things when you read about it: what has been studied, what is being marketed, and what a regulator has actually said. Those three often move at different speeds, and conflating them leads to confusion.
What "not yet part of the program" actually means
This phrase is a statement about where telos rx's own clinical review currently stands. It is not a statement about the substance's ultimate future.
It could remain outside the program indefinitely, or it could be added later. Neither outcome is predictable from where things stand today.
Telos rx deliberately avoids language that implies a specific timeline for substances in this category, because no such timeline exists. The honest position is that 5-Amino-1MQ is under review, and no further claim can responsibly be made beyond that.
If your priority is starting a compounded peptide protocol now rather than waiting on an uncertain future, it makes more sense to look at what is currently available.
Which is right for you
Since telos rx does not offer 5-Amino-1MQ today, the more useful question for most people is what is actually available right now. If your interest is metabolic and energy-related, NAD+ nasal spray is a compounded option telos rx currently offers, as low as $116 a month.
Other currently available options include BPC-157 for repair-focused protocols, PT-141 for sexual wellness, and sermorelin for growth hormone support. Each is compounded, not FDA-approved, prepared by partner compounding pharmacies, and available through an asynchronous intake.
If NAD+ nasal spray sounds like the closer fit for your goals today, start an online visit to see if it is appropriate for you. This is a different, currently available protocol, not a substitute for 5-Amino-1MQ specifically, and any decision to start is subject to medical approval by a licensed provider.
Frequently Asked Questions
Is 5-Amino-1MQ a peptide?
No. It is a small molecule studied for NNMT inhibition, not a chain of amino acids. It is often discussed alongside peptides because of how it is researched and compounded, but the chemistry is different.
Does telos rx sell 5-Amino-1MQ?
No. Telos rx does not currently offer 5-Amino-1MQ for compounding. It is not yet part of the program, and telos rx does not have a confirmed timeline for whether that will change.
Is 5-Amino-1MQ FDA-approved?
No. Compounded medications broadly are not FDA-approved, and 5-Amino-1MQ specifically is not currently offered by telos rx at all.
Is 5-Amino-1MQ the same as a GLP-1 medication?
No. GLP-1 medications work on appetite hormone pathways. 5-Amino-1MQ is studied through NNMT inhibition in fat and liver cells, an entirely different proposed mechanism.
Can I buy 5-Amino-1MQ from a research-chemical website instead?
Telos rx cannot speak to the safety or sourcing of outside sellers. Products sold that way are typically not intended for human use and are not prepared under pharmacy oversight.
What can I start with telos rx today instead?
Telos rx currently offers BPC-157, PT-141, NAD+ nasal spray, and sermorelin. A provider can help you decide whether any of these fit your goals through an asynchronous intake.
This article is general information, not medical advice, and does not replace guidance from your own provider. Compounded medications are not FDA-approved. Telos rx works with partner compounding pharmacies that are LegitScript-certified.
5-Amino-1MQ is not currently offered by telos rx.